Cohn and Wolfe wins work on new inhalers

Boehringer Ingelheim, the German pharmaceutical giant, has chosen Cohn and Wolfe to support the global introduction of non-CFC propelled inhalers.

Boehringer Ingelheim, the German pharmaceutical giant, has chosen

Cohn and Wolfe to support the global introduction of non-CFC propelled

inhalers.



The programme is likely to last for between three and five years.



Inhalers used for the treatment of asthma and other respiratory

conditions, are currently propelled by CFCs. The Montreal Protocol, an

international treaty signed by 130 countries in 1987, resulted in the

ban of all CFCs by 2005.



Martin Ellis, deputy managing director at C&W, said: ’The key task is to

ensure a seamless transition. Patients get very concerned about changes

of medication and the medical profession needs to know that the new

inhalers are as effective.’



The programme will also address the differing interpretations of the

Montreal Protocol by regulatory authorities worldwide. Some may phase

out the CFC inhalers gradually, while others may ban them

immediately.



The strategy devised by Cohn and Wolfe will be implemented in individual

markets by local PR agencies.



- Cohn and Wolfe has expanded its healthcare team with the appointment

of Fiona Stratford as account director. Stratford was made redundant

from her job as public affairs manager at Bristol Myers Squibb in

June(PR Week, 13 June). ’Six months in-house gave me a wealth of

experience,’ said Stratford, who joined BMS in November from

Burson-Marsteller.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.